AriBioLab Co.,Ltd.

₩4,300As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:261780Healthcare
Country South Korea
PE (Fwd) •••
TSR 5Y CAGR (16.13%)
Div yield —
ROE (92.28%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.16
PE TTM —
TSR TTM 57.80%
Mkt cap ₩120.5B
ROIC (33.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,334
0.78%
(50.76%)
Sell 5|12|7|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
96.83
103.64
102.50
98.51
15.18%
17.16%
6.00%
5.30%
Revenue₩B
13.34
14.08
13.74
13.36
9.81%
11.89%
5.72%
4.39%
Peers (US$88.81M)
Cap (US$)
PE
88.47M
132.0x
83.39M
—
Capital
TTM
5Y
10Y
Leveragex
1.868
0.020
0.016
EBIT/Intx
0.957
0.980
0.905
Own earn%
58.78
(73.62)
(100.92)
Sh yield%
38.73
26.55
26.56
Owners
Insiders/Inst%
0.39
67.31
Short interest%
2.61
SBC / revenue%
2.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
32